Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 26, 2017
April 11, 2024
eed3bedd-c895-4ca2-bd44-b1c92b786f14
Related Documents
Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment: Draft Guidance for Industry
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment
Guidance DocumentJuly 19, 2024Center for Drug Evaluation and Research
Stimulant Use Disorders: Developing Drugs for Treatment
Guidance DocumentOctober 5, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.